Q3 2020 Biosyent Inc Earnings Call Transcript
© -
Hello, and welcome to the BioSyent Q3 2020 Results Presentation. My name is René Goehrum, and I'm the President and CEO of the company.
I'm going to start today's presentation with a look at our sales, EBITDA and net income after tax for the quarter ended September 30. So as you can see, our sales were just short of $5.8 million, and that was 7% below the year ago quarter. So that's made up of a couple of different elements that I just want to walk you through.
So our Canadian pharmaceutical business performed well. It was up 14% versus the year ago quarter. Our international pharmaceutical business, which is essentially selling FeraMAX oral iron supplement to customers outside of Canada, was down dramatically, down 99%.
So there's a couple of things that work there. One is that we are having some challenges in our largest market with that product, COVID related, and I'll speak to that in a couple of slides. The other is that in that quarter, the year ago quarter, our comp quarter was an
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
